Insider Actions for Illumina Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 08/30/2021 |
Susan H. Tousi SVP, Chief Commercial Officer |
300 | Disposition at $463.5 per share. | 139,050 |
| 08/23/2021 |
Charles E. Dadswell SVP & General Counsel |
314 | Disposition at $489.1 per share. | 153,577 |
| 08/18/2021 |
Alex Aravanis SVP, Chief Technology Officer |
9,949 | Derivative/Non-derivative trans. at $510.61 per share. | 5,080,058 |
| 08/18/2021 |
Alex Aravanis SVP, Chief Technology Officer |
21,653 | Award at $510.61 per share. | 11,056,238 |
| 08/04/2021 |
Susan H. Tousi SVP, Chief Commercial Officer |
1,000 | Disposition at $500 per share. | 500,000 |
| 07/28/2021 |
Susan H. Tousi SVP, Chief Commercial Officer |
300 | Disposition at $486.41 per share. | 145,923 |
| 07/22/2021 |
Charles E. Dadswell SVP & General Counsel |
314 | Disposition at $482.23 per share. | 151,420 |
| 06/28/2021 |
Susan H. Tousi SVP, Chief Commercial Officer |
300 | Disposition at $478.95 per share. | 143,685 |
| 06/22/2021 |
Charles E. Dadswell SVP & General Counsel |
314 | Disposition at $461.01 per share. | 144,757 |
| 06/11/2021 |
Phillip G. Febbo SVP Chief Medical Officer |
290 | Disposition at $449.02 per share. | 130,215 |
| 06/11/2021 |
Phillip G. Febbo SVP Chief Medical Officer |
400 | Disposition at $447.65 per share. | 179,060 |
| 06/11/2021 |
Phillip G. Febbo SVP Chief Medical Officer |
310 | Disposition at $446.17 per share. | 138,312 |
| 06/10/2021 |
Caroline D. Dorsa Director |
1,000 | Disposition at $450 per share. | 450,000 |
